Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,197.00    -18.00 (-1.48%)
Bid:
1,198.00
Ask:
1,200.00
Spread: 2.00 (0.167%)
Market Cap: £832.43m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

7 Oct 2008 07:00

RNS Number : 2159F
CVS Group plc
07 October 2008
Β 

ο»Ώ

For ImmediateΒ Release

7 OctoberΒ 2008

CVS Group plc

("CVS" or the "Company")

AcquisitionΒ ofΒ Rossendale Pet CrematoriumΒ Limited

CVS, one of theΒ UK's leading providers of veterinary services, is pleased to announce the acquisition ofΒ Rossendale Pet Crematorium Limited ('the crematorium').

Β 

The acquisition, which includes the freehold property from which the crematorium operates, has been financed wholly from the Company's cash flow,Β continuing to demonstrateΒ the ability of the Company to finance its acquisition pipeline directly from internally generated cash.

Β 

BasedΒ in Lancashire,Β within aΒ thirteen acreΒ site, the crematoriumΒ andΒ MemorialΒ GardensΒ wereΒ established in 1967,Β aiming to provide bereaved pet owners with the best and widest options in coping with the death of their pets.Β 

CVS will assume all management responsibilities for the crematorium following completion of the acquisition including the nine current employees.

In the year endedΒ 31 December 2007,Β theΒ crematoriumΒ achieved an Operating Profit of Β£136,000Β on turnover of Β£490,000Β and had gross assets of Β£503,000.

The acquisition of a crematoriumΒ will be a great enhancement toΒ CVS' existingΒ portfolio of 151Β veterinaryΒ surgeriesΒ andΒ 4Β veterinary laboratories.Β Further broadeningΒ theΒ veterinary servicesΒ offering,Β the acquisition providesΒ a new divisionΒ which, in line with CVS'Β statedΒ strategy,Β will allow the CompanyΒ to continue to generate stronger returns through vertical integration of key suppliers to the veterinary market.

CVS owned practices send minimal levels of work to the crematorium, therefore providing the opportunity for CVS surgeries to cascade work there post completion, where logistically suitable.

Commenting on theΒ acquisition,Β CVS Chief Executive Simon Innes said:Β 

"The acquisition of RossendaleΒ PetΒ Crematorium is an important addition to the CVS group of businessesΒ as well as a natural progression for our Company. In line with all acquisitions to date, it offers aΒ highΒ quality business with dedicated professionals.

The potential forΒ cost synergiesΒ means thatΒ weΒ will enhanceΒ ourΒ shareholder returnsΒ at the same time as improving ourΒ clientΒ offering."

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

Buchanan Communications

Richard Oldworth

Suzanne Brocks

020 7466 5000

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQILFITIVLRIIT
Date   Source Headline
30th Sep 20207:00 amRNSExercise of Options
24th Sep 20207:00 amRNSFinal Results for the year ended 30 June 2020
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20207:00 amRNSExercise of Options
18th Aug 20203:54 pmRNSHolding(s) in Company
31st Jul 20207:00 amRNSExercise of Options
24th Jul 20207:00 amRNSTrading Update
16th Jul 20207:00 amRNSBoard Appointment
30th Jun 202011:15 amRNSExercise of Options
26th Jun 20207:00 amRNSChange of Company Secretary
9th Jun 202012:29 pmRNSDirector/PDMR Shareholding
1st Jun 202011:50 amRNSExercise of Options
7th May 20209:10 amRNSHolding(s) in Company
30th Apr 202010:25 amRNSExercise of Options
14th Apr 20204:00 pmRNSHolding(s) in Company
9th Apr 202012:23 pmRNSHolding(s) in Company
2nd Apr 20202:29 pmRNSHolding(s) in Company
31st Mar 20201:42 pmRNSExercise of Options
30th Mar 202011:45 amRNSDirector/PDMR Shareholding
27th Mar 20202:52 pmRNSDirector/PDMR Shareholding
27th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Mar 20209:54 amRNSFormatting Replacement: Interim Results
27th Mar 20207:00 amRNSInterim Results
20th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSHolding(s) in Company
12th Mar 20209:34 amRNSHolding(s) in Company
9th Mar 20205:01 pmRNSHolding(s) in Company
9th Mar 20209:18 amRNSHolding(s) in Company
6th Mar 20205:27 pmRNSHolding(s) in Company
6th Mar 20202:47 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSExercise of Options
7th Feb 20207:00 amRNSTrading Update
31st Jan 20205:47 pmRNSOption exercise and block listing update
27th Jan 20204:12 pmRNSHolding(s) in Company
24th Jan 20204:22 pmRNSHolding(s) in Company
22nd Jan 20205:08 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSHolding(s) in Company
10th Jan 20203:46 pmRNSLong Term Incentive Plan Awards - replacement
10th Jan 20209:27 amRNSHolding(s) in Company
8th Jan 20203:57 pmRNSLong Term Incentive Plan Awards
7th Jan 20204:58 pmRNSHolding(s) in Company
6th Jan 202012:02 pmRNSPrice Monitoring Extension
2nd Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20199:29 amRNSHolding(s) in Company
20th Dec 20193:15 pmRNSLong Term Incentive Plan Awards
12th Dec 20199:39 amRNSHolding(s) in Company
2nd Dec 201912:17 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSBoard Appointments
29th Nov 20197:00 amRNSResult of AGM
28th Nov 20197:00 amRNSAnnual General Meeting Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.